Genomic epidemiology of complex disease: The need for an electronic evidence-based approach to research synthesis

American Journal of Epidemiology

Volumn 162, Issue 4, 2005, Pages 297-301

  Bracken, Michael B ^a,b,c  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Cochrane Neonatal Review Group ^*  (United States)

^c Cochrane Methods Group ^*  (United States)

Author keywords

Epidemiology; Genes; Genetics; Genome; Genome, human; Meta analysis; Research; Review, systematic

Indexed keywords

EPIDEMIOLOGICAL PHENOMENA;

CLINICAL TRIAL; DNA MICROARRAY; ELECTRONICS; ENVIRONMENTAL FACTOR; EVIDENCE BASED MEDICINE; GENE IDENTIFICATION; GENE MAPPING; GENETIC ASSOCIATION; GENETIC DISORDER; GENETIC EPIDEMIOLOGY; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; PHENOTYPE; REVIEW; SYSTEMATIC REVIEW; CHROMOSOME MAP; HUMAN GENOME PROJECT; META ANALYSIS; PUBLISHING;

CHROMOSOME MAPPING; ELECTRONICS; EVIDENCE-BASED MEDICINE; HUMAN GENOME PROJECT; HUMANS; META-ANALYSIS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PUBLICATION BIAS;

EID: 23944439954     PISSN: 00029262     EISSN: 14766256     Source Type: Journal    
DOI: 10.1093/aje/kwi200     Document Type: Review

References (51)

1. Risch NJ. Searching for genetic determinants in the new millennium. Nat Rev Genet 2000;405:847-56.
2. Bell J. Predicting disease using genomics. Nature 2004;429:453-6.
3. Potter JD. At the interfaces of epidemiology, genetics and genomics. Nature 2001;2:142-7.
4. Kendal WS. An exponential dispersion model for the distribution of human single nucleotide polymorphisms. Mol Biol Evol 2003;20:579-90.
5. Johnson GCL, Esposito L, Barratt BJ, et al. Haplotype tagging for the identification of common disease genes. Nat Genet 2001;29:233-7.
6. Schena M. Microarrays as toxin sensors. Pharmacogenomics J 2003;3:125-7.
7. Schena M, Shalon D, Davis RW, et al. Quantitative monitoring of gene expression patterns with a complementary DNA microarray. Science 1995;270:467-70.
8. Kurz T, Altmueller J, Strauch K, et al. A genome-wide screen on the genetics of atopy in a multiethnic European population reveals a major atopy locus on chromosome 3q21.3. Allergy 2005;60:192-9.
9. Ozaki K, Ohnishi Y, Iida A, et al. Functional SNPs in the lymphotoxin-α gene that are associated with susceptibility to myocardial infarction. Nat Genet 2002;32:650-4.
10. Hirschhorn JN, Daly MJ. Genome-wide association studies for common diseases and complex traits. Nat Rev Genet 2005;6:95-108.
11. Wang WYS, Barratt BJ, Clayton DG, et al. Genome-wide association studies: theoretical and practical concerns. Nat Rev Genet 2005;6:109-18.
12. Hoh J, Ott J. Mathematical multi-locus approaches to localizing complex human trait genes. Nat Rev Genet 2003;4:701-9.
13. Hoh J, Ott J. Genetic dissection of diseases: design and methods. Curr Opin Genet Dev 2004;14:229-32.
14. Reiner A, Yekutieli D, Benjamini Y. Identifying differentially expressed genes using false discovery rate controlling procedures. Bioinformatics 2003;19:368-75.
15. Klein RJ, Zeiss C, Chew EY, et al. Complement factor H polymorphism in age-related macular degeneration. Science 2005;308:385-9.
16. Clayton D, McKeigue PM. Epidemiological methods for studying genes and environmental factors in complex diseases. Lancet 2001;358:1356-60.
17. Carlson CS, Eberle MA, Kruglyak L, et al. Mapping complex disease loci in whole-genome association studies. Nature 2004;429:446-52.
18. Khoury MJ, Millikan R, Little J, et al. The emergence of epidemiology in the genomics age. Int J Epidemiol 2004;33:936-44.
19. Newman SA, Muller GB. Epigenetic mechanisms of character origination. J Exp Zool 2000;288:304-17.
20. Jablonka E. Epigenetic epidemiology. Int J Epidemiol 2004;33:929-35.
21. Egger G, Liang G, Aparicio A, et al. Epigenetics in human disease and prospects for epigenetic therapy. Nature 2004;429:457-63.
22. Feinberg AP, Tycko B. The history of cancer epigenetics. Nat Rev Cancer 2004;4:143-53.
23. Begg CB. On the use of familial aggregation in population-based case probands for calculating penetrance. J Natl Cancer Inst 2002;94:1221-6.
24. Szabo P, Tang SH, Rentsendorj A, et al. Maternal-specific footprints at putative CTCF sites in the H19 imprinting control region give evidence for insulator function. Curr Biol 2000;10:607-10.
25. 2-adrenergic receptor. Am J Respir Crit Care Med 1997;156:S156-62.
26. Colhoun HM, McKeigue PM, Smith GD. Problems of reporting genetic associations with complex outcomes. Lancet 2003;361:865-72.
27. Ioannidis JPA, Ntzani EE, Trikalinos TA, et al. Replication validity of genetic association studies. Nat Genet 2001;29:306-9.
28. Lalouel JM, Rohrwasser A. Power and replication in case-control studies. Am J Hypertens 2002;15:201-5.
29. Lander E, Kruglyak L. Genetic dissection of complex traits: guidelines for interpreting and reporting linkage results. Nat Genet 1995;11:241-7.
30. Counsell CE, Clarke MJ, Slattery J, et al. The miracle of DICE therapy for acute stroke: fact or fictional product of subgroup analysis? BMJ 1994;309:1677-81.
31. Bracken MB. Statistical methods for analysis of effects of treatment in overviews of randomized trials. In: Sinclair JC, Bracken MB, eds. Effective care of the newborn infant. New York, NY: Oxford University Press, 1992.
32. Daher S, Shulzhenko N, Morgun A, et al. Associations between cytokine gene polymorphisms and recurrent pregnancy loss. J Reprod Immunol 2003;58:69-77.
33. Thompson SG, Higgins JPT. How should meta-regression analyses be undertaken and interpreted? Stat Med 2002;21:1559-73.
34. Clarke MJ, Stewart LA. Obtaining individual patient data from randomized clinical trials. In: Egger M, Smith GD, Altman DG, eds. Systematic reviews in health care: meta-analysis in context. London, United Kingdom: BMJ Publishing Group, 2001.
35. Ioannidis JP, Rosenberg PS, Goedert JJ, et al. Effects of CCR5-Delta32, CCR2-64I, and SDF-1 3′ A alleles on HIV-1 disease progression: an international meta-analysis of individual-patient data. Ann Intern Med 2001;135:782-95.
36. Environmental Genome Project: polymorphisms and genes (www.niehs.nih.gov/envgenom/snpsdb.htm). Accessed April 27, 2005.
37. GenBank database (www.psc.edu/general/software/packages/genbank/genbank. html). Accessed April 27, 2005.
38. ALFRED: The ALlele FREquency Database. A resource of gene frequency data on human populations supported by the US National Science Foundation (http://alfred.med.yale.edu/alfred/index.asp). Accessed April 20, 2005.
39. Genomics and disease prevention: Genotype Prevalence Database (www.cdc.gov/genomics/search/aboutGTP.htm). Accessed April 27, 2005.
40. Allele frequencies in worldwide populations (www. allelefrequencies.net/) . Accessed April 27, 2005.
41. National Cancer Institute SNP500Cancer database (www.snp500cancer.nci. nih.gov). Accessed April 27, 2005.
42. International HapMap Project (www.hapmap.org/). Accessed July 10, 2004.
43. Sackett DL, Straus SE, Richardson SW, et al. Evidence-based medicine: how to practice and teach EMB. London, United Kingdom: Harcourt Publishers Limited, 2000.
44. Egger M, Smith GD, Altman DG. Systematic reviews in health care: meta-analysis in context. London, United Kingdom: BMJ Publishing Group, 2001.
45. Centers for Disease Control, Human Genome Epidemiology Network (http://www.cdc.gov/genomics/hugenet/). Accessed April 20, 2005.
46. Little J, Khoury MJ, Bradley L, et al. The Human Genome Project is complete. How do we develop a handle for the pump? Am J Epidemiol 2003;157:667-73.
47. Little J, Bradley L, Bray MS, et al. Reporting, appraising, and integrating data on genotype prevalence and gene-disease associations. Am J Epidemiol 2002;156:300-10.
48. The Campbell Collaboration (http://www.campbellcollaboration.org/). 2004.
49. Brennan P, Lewis S, Hashibe M, et al. Pooled analysis of alcohol dehydrogenase genotypes and head and neck cancer: a HuGE review. Am J Epidemiol 2004;159:1-16.
50. Chan AW, Hróbjartsson A, Haahr MT, et al. Empirical evidence for selective reporting of outcomes in randomized trials. Comparison of protocols to published articles. JAMA 2004;291:2457-65.
51. The Cochrane Library, Update Software Ltd (http://www.update-software. com/cochrane/). 2004.